All these results confirmed that MRPL12, MRPL13 and POP1 acted as oncogenes in breast cancer cells, therefore, they might be regarded as prognostic indicators in breast cancer, but also could be designed as therapeutic targets of breast cancer. The gene discussed is POP1; the disease is breast carcinoma.